Wells Fargo’s Candel Therapeutics CADL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $105K | Buy |
20,775
+7,186
| +53% | +$36.4K | ﹤0.01% | 4764 |
|
|
2025
Q1 | $76.8K | Buy |
13,589
+3,467
| +34% | +$19.6K | ﹤0.01% | 4780 |
|
|
2024
Q4 | $87.9K | Buy |
10,122
+3,935
| +64% | +$34.2K | ﹤0.01% | 4779 |
|
|
2024
Q3 | $42.9K | Sell |
6,187
-157
| -2% | -$1.09K | ﹤0.01% | 5001 |
|
|
2024
Q2 | $39.3K | Buy |
6,344
+6,229
| +5,417% | +$38.6K | ﹤0.01% | 5019 |
|
|
2024
Q1 | $182 | Buy |
115
+2
| +2% | +$3 | ﹤0.01% | 6119 |
|
|
2023
Q4 | $166 | Buy |
113
+5
| +5% | +$7 | ﹤0.01% | 6208 |
|
|
2023
Q3 | $99 | Buy |
108
+4
| +4% | +$4 | ﹤0.01% | 6399 |
|
|
2023
Q2 | $131 | Buy |
104
+4
| +4% | +$5 | ﹤0.01% | 6502 |
|
|
2023
Q1 | $135 | Buy |
100
+2
| +2% | +$3 | ﹤0.01% | 6549 |
|
|
2022
Q4 | $175 | Buy |
98
+2
| +2% | +$4 | ﹤0.01% | 6326 |
|
|
2022
Q3 | $0 | Buy |
96
+35
| +57% | – | ﹤0.01% | 6365 |
|
|
2022
Q2 | $0 | Buy |
+61
| New | – | ﹤0.01% | 6532 |
|
|
2021
Q4 | – | Sell |
-1,054
| Closed | -$12K | – | 6676 |
|
|
2021
Q3 | $12K | Buy |
+1,054
| New | +$12K | ﹤0.01% | 5818 |
|